Nipro Company, Ltd.
Japan Last updated 22 Oct 2026 Part of Nipro Corporation
- Devices
- 163
- Registries
- EUDAMEDFDA 510(k)
- FDA recalls
- 1
Catalogue
Sureflux Ref SF-11N-GJ
Solacea Ref SLC-21H-GJ
Sureflux Ref SF-11E-GJ
Sureflux Ref SF-11UX-PO-GJ
Sureflux Ref SF-21UX-GJ
Sureflux Ref SF-21UX-PO-GJ
Sureflux Ref SF-25UX-GJ
Solacea Ref SLC-17H-GJ
Sureflux Ref SF-19E-GJ
Vmk Endoneedle Ref EN-2825-ET
Diacap Ref 7202215
Diacap Ref 7202017
Sureflux Ref SF-09E-PO-GJ
Sureflux Ref SF-13N-GJ
Solacea Ref SLC-15H-GJ
Fb Ref FB 15U-GJ
Solacea Ref SLC-25H-GJ
Elisio Ref ELI-19L-PO-GC
Elisio Ref ELI-15HX-GJ
Sureflux Ref SF-13E-PO-GJ
Sureflux Ref SF-17UX-PO-GJ
Sureflux Ref SF-05L-PO-GJ
Sureflux Ref SF-19N-GJ
Sureflux Ref SF-07L-PO-GJ
Sureflux Ref SF-13E-GJ
Sureflux Ref SF-17UX-GJ
Safetouch Dialysis Cath Plus Ref AVSF-CATHP-1525-GJ
Solacea Ref SLC-19H-GJ
Sureflux Ref SF-17N-GJ
Diacap Ref 7202019
Sureflux Ref SF-19E-PO-GJ
Sureflux Ref SF-13G-GJ
Elisio Ref ELI-21L-GJ
Sureflux Ref SF-19UX-PO-GJ
Sureflux Ref SF-21E-PO-GJ
Elisio Ref ELI-15L-GJ
Elisio Ref ELI-19L-PO-GJ
Safetouch Dialysis Cath Plus Ref AVSF-CATHP-1625-GJ
Elisio Ref ELI-21L-PO-GJ
Sureflux Ref SF-11G-GJ
Sureflux Ref SF-21L-GJ
Elisio Ref ELI-15L-PO-GJ
Elisio Ref ELI-19M-GJ
Sureflux Ref SF-09E-GJ
Sureflux Ref SF-15UX-PO-GJ
Diacap Ref 7202221
Elisio Ref ELI-17H-GJ
Elisio Ref ELI-11M-GJ
Elisio Ref ELI-11K-GJ
Showing 51-100 of 163
FDA recalls
FDA recall records list 1 recall initiated by Nipro Company, Ltd., initiated on 2002-11-08. By recorded status: 1 terminated. The reasons filed fall into these groups: mechanical integrity. A recall is often a precaution started by the manufacturer, and a count of records is not a verdict on a company.
2002
- 8 Nov 2002 Z-0408-03 Unclassified (pre-2012) Terminated Air or fluid leakage at the hub/needle junction.
What Nipro Company, Ltd. makes
Nipro Company, Ltd. manufactures bedside medical consoles, including the HA-57P model, and intravenous infusion pumps such as the BIP-BH blood and heparin pump. These devices are designed for hospital use to administer fluids and medications while providing integrated monitoring and control functions at the patient’s bedside.
The company’s products fall under FDA Class II regulatory classification and are listed via the 510(k) clearance pathway. These devices are intended for use in the United States, where they must comply with applicable FDA requirements for safety and performance.
Information
- Address
- 3-26, Senriokashinmachi, Settsu, Osaka, Japan
- Website
- nipro.co.jp
- [email protected]
- PRRC contact
- Toyoshi YOSHIDA
- EUDAMED SRN
- JP-MF-000026759